These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

317 related items for PubMed ID: 19199349

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Optimal treatment of the axilla after positive sentinel lymph node biopsy in early invasive breast cancer. Early results of the OTOASOR trial].
    Sávolt A, Musonda P, Mátrai Z, Polgár C, Rényi-Vámos F, Rubovszky G, Kovács E, Sinkovics I, Udvarhelyi N, Török K, Kásler M, Péley G.
    Orv Hetil; 2013 Dec 08; 154(49):1934-42. PubMed ID: 24292111
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Omission of axillary lymph node dissection for clinically node negative early-stage breast cancer patients.
    Kobayashi R, Shiraishi K, Iwase S, Ohtomo K, Nakagawa K.
    Breast Cancer; 2015 Nov 08; 22(6):657-63. PubMed ID: 24756246
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Surgical management of early stage invasive breast cancer: a practice guideline.
    McCready D, Holloway C, Shelley W, Down N, Robinson P, Sinclair S, Mirsky D, Breast Cancer Disease Site Group of Cancer Care, Ontario's Program in Evidence-Based Care.
    Can J Surg; 2005 Jun 08; 48(3):185-94. PubMed ID: 16013621
    [Abstract] [Full Text] [Related]

  • 8. Axillary treatment in conservative management of operable breast cancer: dissection or radiotherapy? Results of a randomized study with 15 years of follow-up.
    Louis-Sylvestre C, Clough K, Asselain B, Vilcoq JR, Salmon RJ, Campana F, Fourquet A.
    J Clin Oncol; 2004 Jan 01; 22(1):97-101. PubMed ID: 14701770
    [Abstract] [Full Text] [Related]

  • 9. Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials.
    EBCTCG (Early Breast Cancer Trialists' Collaborative Group), McGale P, Taylor C, Correa C, Cutter D, Duane F, Ewertz M, Gray R, Mannu G, Peto R, Whelan T, Wang Y, Wang Z, Darby S.
    Lancet; 2014 Jun 21; 383(9935):2127-35. PubMed ID: 24656685
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Omission of axillary staging in elderly patients with early stage breast cancer impacts regional control but not survival: A systematic review and meta-analysis.
    Liang S, Hallet J, Simpson JS, Tricco AC, Scheer AS.
    J Geriatr Oncol; 2017 Mar 21; 8(2):140-147. PubMed ID: 27986500
    [Abstract] [Full Text] [Related]

  • 13. Long-term prognoses and outcomes of axillary lymph node recurrence in 2,578 sentinel lymph node-negative patients for whom axillary lymph node dissection was omitted: results from one Japanese hospital.
    Ogiya A, Kimura K, Nakashima E, Sakai T, Miyagi Y, Iijima K, Morizono H, Makita M, Horii R, Akiyama F, Iwase T.
    Breast Cancer; 2016 Mar 21; 23(2):318-22. PubMed ID: 25376341
    [Abstract] [Full Text] [Related]

  • 14. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
    Gipponi M, Bassetti C, Canavese G, Catturich A, Di Somma C, Vecchio C, Nicolò G, Schenone F, Tomei D, Cafiero F.
    J Surg Oncol; 2004 Mar 21; 85(3):102-11. PubMed ID: 14991881
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Primary axillary radiotherapy as axillary treatment in breast-conserving therapy for patients with breast carcinoma and clinically negative axillary lymph nodes.
    Hoebers FJ, Borger JH, Hart AA, Peterse JL, Th EJ, Lebesque JV.
    Cancer; 2000 Apr 01; 88(7):1633-42. PubMed ID: 10738222
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. "Axillary recurrences after sentinel lymph node biopsy: a multicentre analysis and follow-up of sentinel lymph node negative breast cancer patients".
    van Wely BJ, van den Wildenberg FJ, Gobardhan P, van Dalen T, Borel Rinkes IH, Theunissen EB, Wijsman JH, Ernst M, van der Pol CC, Madsen EV, Vles WJ, Wauters CA, de Wilt JH, Strobbe LJ.
    Eur J Surg Oncol; 2012 Oct 01; 38(10):925-31. PubMed ID: 22633152
    [Abstract] [Full Text] [Related]

  • 19. Therapeutic options and results for the management of minimally invasive carcinoma of the breast: influence of axillary dissection for treatment of T1a and T1b lesions.
    White RE, Vezeridis MP, Konstadoulakis M, Cole BF, Wanebo HJ, Bland KI.
    J Am Coll Surg; 1996 Dec 01; 183(6):575-82. PubMed ID: 8957459
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.